Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.

Dodangeh S, Zarepour P, Mossavarali S, Sanjari M, Saeedi Moghaddam S, Tabatabaei-Malazy O

Open source

DOI
10.1007/s40200-026-02068-2
Published
2026 Dec
Container
Journal of diabetes and metabolic disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40200-026-02068-2,
  title = {Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.},
  author = {Dodangeh S and Zarepour P and Mossavarali S and Sanjari M and Saeedi Moghaddam S and Tabatabaei-Malazy O},
  year = {2026},
  journal = {Journal of diabetes and metabolic disorders},
  doi = {10.1007/s40200-026-02068-2},
  url = {https://doi.org/10.1007/s40200-026-02068-2}
}

RIS

TY  - JOUR
TI  - Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.
AU  - Dodangeh S
AU  - Zarepour P
AU  - Mossavarali S
AU  - Sanjari M
AU  - Saeedi Moghaddam S
AU  - Tabatabaei-Malazy O
PY  - 2026
JO  - Journal of diabetes and metabolic disorders
DO  - 10.1007/s40200-026-02068-2
UR  - https://doi.org/10.1007/s40200-026-02068-2
ER  - 

APA

S, D., P, Z., S, M., M, S., S, S. M., & O, T. (2026). Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.. Journal of diabetes and metabolic disorders. https://doi.org/10.1007/s40200-026-02068-2

Source records